TP53 and cancer: Furthermore, ribosome-free rpL3 has also been identified as a p53-independent regulator of nuclear factor kappa-light-chain-enhancer of activated B cells (NFκB), a key factor with a role as a pivotal link between inflammation and cancer [86,87].